CeQur
CeQur is commercializing advanced, simple-to-use insulin-delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. Established in 2008, CeQur is headquartered in Switzerland.
Last updated on
About CeQur
Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$272MCategory
Location
City
GreenvilleState
South CarolinaCountry
United StatesTech Stack (21)
